PortfoliosLab logo

Adaptive Biotechnologies Corporation (ADPT)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS00650F1093
CUSIP00650F109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$11.45
Year Range$6.40 - $39.78
EMA (50)$9.26
EMA (200)$17.08
Average Volume$1.73M
Market Capitalization$1.62B

ADPTShare Price Chart


Chart placeholderClick Calculate to get results

ADPTPerformance

The chart shows the growth of $10,000 invested in Adaptive Biotechnologies Corporation in Jun 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,841 for a total return of roughly -71.59%. All prices are adjusted for splits and dividends.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%MarchAprilMayJuneJulyAugust
-33.82%
-9.63%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M25.82%8.19%
6M-28.03%-7.42%
YTD-59.19%-13.03%
1Y-69.35%-5.85%
5Y-33.30%11.88%
10Y-33.30%11.88%

ADPTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-37.85%-17.26%-3.81%-40.56%-5.21%3.45%13.23%25.00%
2021-6.19%1.98%-28.83%3.33%-9.11%8.07%-10.28%-0.93%-6.42%-1.71%-21.91%7.55%
2020-0.05%-6.04%-1.14%15.23%20.90%25.01%-22.86%11.50%16.87%-5.24%4.64%22.63%
201919.85%-20.19%31.91%-39.23%-15.65%4.32%10.04%

ADPTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.86. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.86
-0.31
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTDividend History


Adaptive Biotechnologies Corporation doesn't pay dividends

ADPTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-83.10%
-13.58%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

ADPTWorst Drawdowns

The table below shows the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adaptive Biotechnologies Corporation is 90.55%, recorded on Jun 13, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.55%Jan 25, 2021350Jun 13, 2022
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-0.85%Jan 15, 20211Jan 15, 20211Jan 19, 20212
-0.71%Jan 20, 20211Jan 20, 20212Jan 22, 20213

ADPTVolatility Chart

Current Adaptive Biotechnologies Corporation volatility is 70.21%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
70.21%
19.67%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)